Cygnus Capital Advisors’s Genprex GNPX Stock Holding History

Cygnus Capital Advisors’s Portfolio GNPX Stock Details GNPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-100	Closed	-$4K	–	83
2026 Q1	$4K	Buy	+100	New	+$4.76K	﹤0.01%	103

Other funds holding GNPX

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EGM

Engineers Gate Manager New York $7.71B AUM 24.88% 1-Year Est. Return

MFA

Mayflower Financial Advisors Boston, Massachusetts $1.16B AUM 24.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return

Cygnus Capital Advisors's GNPX Position: Q2 2026 in Review

Cygnus Capital Advisors sold out of Genprex (GNPX) in Q2 2026, closing a stake of 100 shares — an estimated $4K sold.

Cygnus Capital Advisors first reported a position in GNPX in Q1 2026 and held it in 1 quarter. The position peaked at $4K in Q1 2026. 17 funds tracked by Wall St. Rank hold GNPX as of Q2 2026.

Cygnus Capital Advisors reported no remaining Genprex position as of Q2 2026 after selling out during the quarter.
Cygnus Capital Advisors sold 100 Genprex shares in Q2 2026, an estimated $4K.
Cygnus Capital Advisors first reported a position in Genprex in Q1 2026 and held it in 1 quarter.
Cygnus Capital Advisors's Genprex position peaked at $4K in Q1 2026.
17 funds tracked by Wall St. Rank held Genprex as of Q2 2026.

Based on Cygnus Capital Advisors's 13F filing for Q2 2026, filed 3 Sep 2026.